Literature DB >> 19232754

Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention.

Manuel F Jiménez-Navarro1, José M Garcia-Pinilla, Lourdes Garrido-Sanchez, Juan H Alonso-Briales, Alejandro Pérez-Cabeza, Carmen Ortiz-García, Jose M Hernández-Garcia, Francisco Tinahones, Eduardo de Teresa.   

Abstract

BACKGROUND: Early de novo diagnosis of diabetes mellitus in patients admitted with acute coronary syndromes who have undergone percutaneous coronary revascularization may have prognostic implications. The ideal diagnostic method and its time of performance are unknown due to the uncertain reproducibility of the oral glucose tolerance test (OGTT).
METHODS: We assessed 88 patients with no known diabetes mellitus admitted with an acute coronary syndrome who underwent successful percutaneous revascularization. The patients received an OGTT the day after coronary revascularization (7.7+/-6 days after admittance in hospital) and 1 month later.
RESULTS: The mean age of the patients was 60.8+/-10.3 years and 82% were men. The most common reason for admission was acute coronary syndrome without ST elevation (42%), followed by acute coronary syndrome with ST elevation (36%) and stable angina (21%). After the first OGTT, 66 patients (75%) were found to have carbohydrate metabolism disorders (41% glucose intolerance and 34% diabetes mellitus). After the second OGTT 39 patients (44.3%) had carbohydrate metabolism disorders (26% glucose intolerance and 18% diabetes mellitus). The correlation between both tests was low (weighted kappa, 0.23+/-0.1; 0.03-0.43) (p=0.02).
CONCLUSIONS: The correlation of the OGTT done in patients admitted with acute coronary syndromes who underwent percutaneous coronary revascularization the day after admittance and the OGTT 1 month later was poor. The prevalence of carbohydrate intolerance in these patients was high. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19232754     DOI: 10.1016/j.ijcard.2009.01.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: when should it be performed?

Authors:  A Kollias; E Diamanti-Kandarakis
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

Review 2.  The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy.

Authors:  Yicong Ye; Hongzhi Xie; Xiliang Zhao; Shuyang Zhang
Journal:  Cardiovasc Diabetol       Date:  2012-12-27       Impact factor: 9.951

3.  Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population.

Authors:  Lingwen Ying; Xingxing He; Xiaojing Ma; Yun Shen; Hang Su; Jiahui Peng; Yufei Wang; Yuqian Bao; Jian Zhou; Weiping Jia
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.